CC
ONCT

Caxton Corporation’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Caxton Corporation’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
2018
Q2 		$763K Buy
2018
Q1 		$877K Sell
2017
Q4 		$799K Hold
2017
Q3 		$531K Buy